- B2B
- Public StagePublicly traded company
- 4.4Work / Life BalanceEmployees rate Pear Therapeutics 4.4/5 on Glassdoor for work / life balance
- 4.5Strong LeadershipEmployees rate Pear Therapeutics 4.5/5 on Glassdoor for faith in leadership
Pear Therapeutics careers
Pear Therapeutics is the leader in prescription digital therapeutics. We aim to redefine medicine by discovering, developing, and delivering clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Pear has a pipeline of products and product candidates across therapeutic areas, including severe psychiatric and neurological conditions. Our lead product, reSET®, treats Substance Use Disorder and was the first prescription digital therapeutic to receive marketing authorization from the FDA to treat disease. Pear’s second product, reSET-O™, for the treatment of Opioid Use Disorder, received marketing clearance from the FDA in December 2018. For more information, visit us at peartherapeutics.com.
Pear Therapeutics hasn't added any jobs yet
Get notified when Pear Therapeutics posts new jobs.
Stephen Kennedy Smith
Bill Greene
Corey McCann
Valuation
$0
Funded over
6 rounds
Latest round
SPAC (Dec 2021)
Pacific Biosciences • Menlo Park • $148k – $222k • yesterday
Noble Biomaterials • Scranton • $64k – $84k • 4 days ago
Syndax Pharmaceuticals • New York City • 1 week ago
Akebia Therapeutics • Oakland • $178k – $220k • 1 week ago
Acquia • Boston • $145k – $158k • 2 weeks ago

